Comparative study between intrathecal magnesium sulphate and intrathecal fentanyl as an adjuvant to Bupivacaine in spinal anesthesia for patients undergoing lower limb surgery

Comparative study between intrathecal magnesium sulphate and intrathecal fentanyl as an adjuvant to bupivacaine in spinal anesthesia for patients undergoing lower limb orthopedic surgery:A randomized double blind clinical study

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012114

Enrollment

100

Registered

2018-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intrathecal bupivacaine and intrathecal magnesium sulphate: 3ml(0.5%) Bupivacaine and 0.1ml magnesium sulphate Control Intervention1: Intrathecal bupivacaine and intrathecal fentanyl: 3

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA group 1 & 2 patients 2.Patients giving valid informed consent 3.Height 150-180cm and those undergoing lower limb orthopedic surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post-operative analgesic effectTimepoint: Post-operative	—

Secondary

Measure	Time frame
Nausea,Vomitting,Hypotension,Bradycardia,Respiratory depression,Pruritus,Urinary retention,Maximum sedation scoreTimepoint: 1min,5min,10min,15min,20min,25min,30min,35min,40min,45min,50min,55min,60min	—

Countries

India

Contacts

Public ContactDr Ajit Gupta

Indira Gandhi Institute of Medical Sciences,Patna

ajpta_igims@yahoo.co.uk9473191810

Outcome results